
Andrew Dubowski
Partner and Co-Founder, Clearpath HealthTech
Clearpath brings regulatory pathway and clinical evidence expertise to the entry plan.
New market entry
Turn a market opportunity into a practical entry plan. AGENCY brings healthcare market research and commercial planning. Clearpath brings regulatory pathway and clinical evidence expertise. Together, we help you understand local requirements, choose your route, assess partners where needed and plan your first foothold.
We agree the scope, outputs and fee before work starts.
From opportunity to an entry plan.
Direct route? Move from route choice to the local plan. Assess a partner only where needed.
The problem
Before you commit, you need to know what local requirements mean for your product, evidence and launch. Then you need a route that fits how the market buys, a capable partner if the route calls for one, and a plan your team can deliver.
When those decisions sit apart, the commercial plan can run ahead of regulatory readiness. A distributor conversation can become the strategy before you have assessed the alternatives.
The solution
You receive a connected set of decisions and documents: what the market requires, how you should enter, who you should work with where needed, and how to build a focused beachhead. Each recommendation makes its evidence, assumptions and next actions clear.


Partner and Co-Founder, Clearpath HealthTech
Clearpath brings regulatory pathway and clinical evidence expertise to the entry plan.

International Market Entry | Board-Level Strategy
Board-level healthcare commercial advice across international market entry, distributor strategy and account-based marketing.

Sales Force Excellence | Playbook Architecture
Co-creator of AGENCY's Playbook Creation training content, connecting marketing positioning with what the sales team does on the ground.
Researches the commercial opportunity, maps buyers and competition, assesses distributor fit and builds the local messaging, campaigns and sales plan.
Assesses the regulatory pathway, clinical evidence requirements and gaps, and the regulatory dependencies that shape your launch. Clearpath can also support claims matrix review within the agreed scope.
Regulatory findings shape the route you choose. That route defines what you need from a local partner. Those decisions become your local commercial plan, with messaging and activity sequenced around the evidence and agreed milestones.
Our approach
Scope the work around your product, target market and current evidence. Complete partner assessment only where your chosen route needs it.
Requirements and evidence
We establish the requirements relevant to your entry plan. Clearpath assesses the regulatory pathway and evidence position; AGENCY connects the findings to the proposed commercial activity. Identify any questions that require separate legal advice.
Direct or partner route
AGENCY researches local buyers, care pathways, funding, competition and access. We compare direct and partner routes against your capability, resources and the regulatory findings.
Only where a partner is needed
Where the route needs a partner, AGENCY defines what a suitable distributor must offer and assesses candidates for market coverage, relevant capabilities and portfolio fit. An existing partner can be assessed against the same criteria.
A focused first foothold
Choose a focused first segment, region or account group. Adapt the proposition to local needs, then specify the sales tools, training, campaigns and customer pathway needed. Sequence the work around regulatory milestones and agree how to review early feedback.
Once the plan is agreed, AGENCY can build the materials, train your team or support campaign delivery and reporting. Commission the support you need through an agreed scope.
Use the first accounts to test the approach. Review what customers chose, what blocked adoption and what needs to change before wider rollout.
Use the learning to refine the plan
A tool for local research
Use the stakeholder problem map to connect local objectives, barriers and buying decisions to the plan.
Stakeholder Problem Mapping.
Understand them
What is the customer looking to achieve? This could be the cadence of their role (“improve clinical outcome delivery”), a project aim (“select a supplier for ventilators”) or an overall target (“hit the end-of-year number”).
What critical factors determine their success? The key milestones, KPIs or values set to determine both how they get there and the end point, or the items that must be achieved.
What is their current approach to the mission? This could be their own methodology, their current supplier, or their intended choice of supplier and why.
Your answer
Based on their plan, what would you recommend changing or adapting to help overcome the barriers? What would you do in their position? Base this on experience, recommendations from peers they respect and best practice, and keep it brand-agnostic.
What is your company’s or product’s approach to delivering the mission? Why are you uniquely placed to support this mission better than anyone else?
What are the first steps to solving the problem, what is your overall plan, and how is it delivered?
Illustrative application | Patient marketing
Illustrative planning example, not a client result.
For a product launched through clinics, a suitable first site can give you a focused place to start. Define its catchment using travel, referral and patient access patterns. Confirm service capacity, funding arrangements and who will respond before you generate interest.
An enquiry shows interest. Clinical suitability and the next care decision remain with the patient and care team.
FREE PRODUCT LAUNCH GUIDE
Start with one clinic or a defined local market. Build the patient pathway, measure what happens and use the evidence to decide where to expand.
Nine pages | Site checklist | Pathway measures | Pilot worksheet
Download the launch guideFree PDF. No sign-up.

Your first step
Start with the New Market Entry Readiness Assessment. Already have a target market or entry plan? Bring your product, current evidence and proposed route to a focused review. We agree the scope, outputs and fee before commissioned work begins.
The Book

You built something that heals. The people who need it most have never heard its name.
Explore the bookBefore we start
Where a formal legal opinion is required, we scope specialist legal input separately. Regulatory assessment and legal opinion are distinct pieces of work.
Yes. Research can compare shortlisted markets against access, demand, competition, funding, relevant regulation and the resources you have. We agree the research question before starting.
We work with your local team to clarify the target accounts, message, training, activity and measures. The plan makes clear what you own, what the distributor owns and how you review progress together.
The research determines that. Keep useful evidence and assets, adapt them to local needs and review requirements, and create what is missing. Translation follows the proposition and audience decisions.
Both. Commission a defined research or planning project, train your team to use the approach, or ask AGENCY to support execution and reporting. The scope follows what your team needs.
Scope the work around your situation
Tell us the product, market and question. We agree the scope, outputs and fee before work starts.
Find the right NHS accounts, assess your readiness, explore campaign decisions or read the thinking behind our work.

See which NHS trusts fit your product, using their stated priorities and the evidence behind each match.
Explore NHS Trust Intelligence
Diagnose a product launch and get three tests to run, or score your marketing department and get 30-day actions. The emailed report is optional.
Find your marketing gaps
Work through the decisions behind a compliant healthcare campaign. See where your approach moves forward or gets stuck.
Play Snake Oil & Ladders
Explore why good healthcare products struggle to reach the people who need them, and how to build demand. Read three free chapters.
Read three free chapters